Tuberculosis & COVID-19 Know the Difference

This fact sheet provides general information on distinguishing between TB and COVID-19 symptoms, as well as information on some risk factors for TB.
This fact sheet provides general information on distinguishing between TB and COVID-19 symptoms, as well as information on some risk factors for TB.
This guide provides clinicians with an overview of drug-resistant tuberculosis. The guide includes tools that can be used by providers who participate in the management of patients with drug-resistant TB.
This fact sheet provides information on signs and symptoms of multi-drug resistant TB (MDR TB), and action steps to be taken if a person (or someone they know) may have been exposed to TB. The material was developed to educate patients and community members at increased risk of MDR TB due to an...
This fact sheet discusses general information about latent TB infection (LTBI), TB transmission, and TB tests. The resource also provides information on LTBI testing, and treatment.
This fact sheet discusses general information about latent TB infection (LTBI), TB transmission, and TB tests. The resource also provides information on LTBI testing, and treatment.
This fact sheet discusses general information about latent TB infection (LTBI), TB transmission, and TB tests. The resource also provides information on LTBI testing, and treatment.
This poster provides steps that the general public can take to prevent active TB disease.
This fact sheet provides brief information on M. bovis, as well as safety and infection control measures for individuals handling carcasses of animals known or suspected to have TB.
This webinar brings together clinicians, academics, researchers, advocates, professional societies, regulatory agencies and industry representatives to align on best practices to improve treatment for HCV in pregnancy. The TiP-HepC Community of Practice is intended for all stakeholders involved in...
This fact sheet provides a general overview of the Minority AIDS Initiative (MAI) and the Minority HIV/AIDS Fund, emphasizing the need to reaffirm our commitment to the MAI, including increasing funding and transparency.